Skip to main
CLYM
CLYM logo

Climb Bio Inc (CLYM)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy CLYM Stock

About Climb Bio Inc (CLYM)

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.
Market cap$120M
Yesterday's volume297.61K
Revenue (TTM)
Avg. daily volume622.57K
EBITDA (TTM)-$59.43M
Open$1.75
Price / earnings ratio-2.34x
Yesterday's range$1.68 - $1.83
Debt / equity0.33x
52 week range$1.05 - $3.3
5 year debt / equity0.07x
Beta (LTM)1.29x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio18.38x
Ex-dividend date
Next earningsMar 24, 2026
Dividend payable date

CLYM Stock Rating

What analysts recommend for CLYM stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Nov 25, 2025, the market cap for CLYM stock is $120.01M

The current P/E ratio for CLYM stock is -2.34

The 52-week high for CLYM stock is $3.30. The current CLYM stock price $undefined is 100.00% below its 52-week high

The 52-week low for CLYM stock is $1.05. The current CLYM stock price $undefined has increased 100.00% from its 52-week low

No, the CLYM stock does not pay dividends to its shareholders

The target price for CLYM stock is $9 based on the average of what a group of analyst think CLYM stock could be worth at a future date. This is not a prediction by Public.com

How to buy CLYM stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CLYM stock

    Navigate to the Explore page. Then, type CLYM into the search bar. When you see CLYM stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CLYM stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Climb Bio Inc Stock Earnings

The value each CLYM share was expected to gain vs. the value that each CLYM share actually gained.

CLYM (CLYM) reported Q3 2025 earnings per share (EPS) of -$0.19, missing estimates of -$0.15 by 26.67%. In the same quarter last year, CLYM's earnings per share (EPS) was $0. CLYM is expected to release next earnings on 03/24/2026, with an earnings per share (EPS) estimate of -$0.20.

Buy CLYM Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.